Danske Bank’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8K Sell
100
-700
-88% -$97.8K ﹤0.01% 788
2025
Q4
$131K Hold
800
﹤0.01% 725
2025
Q3
$107K Hold
800
﹤0.01% 850
2025
Q2
$99.5K Buy
+800
New +$102K ﹤0.01% 852
2024
Q4
Sell
-200
Closed -$29.8K 1603
2024
Q3
$29.8K Sell
200
-16,788
-99% -$2.41M ﹤0.01% 1280
2024
Q2
$2.14M Sell
16,988
-16,300
-49% -$2.55M 0.01% 619
2024
Q1
$6.12M Buy
+33,288
New +$6.34M 0.02% 533

Other funds holding RGEN

Danske Bank's RGEN Position: Q1 2026 in Review

Danske Bank reduced its Repligen (RGEN) stake by 88% in Q1 2026, selling an estimated $97.8K and leaving 100 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #788.

Danske Bank first reported a position in RGEN in Q1 2024 and has held it in 7 quarters since. The position peaked at $6.12M in Q1 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Danske Bank held 100 shares of Repligen worth $11.8K as of Q1 2026.
  • Danske Bank sold 700 Repligen shares in Q1 2026, an estimated $97.8K.
  • Repligen made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #788 holding.
  • Danske Bank first reported a position in Repligen in Q1 2024 and has held it in 7 quarters since.
  • Danske Bank's Repligen position peaked at $6.12M in Q1 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.